Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Cash Flows

v3.22.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2020
Cash flows from operating activities:      
Net income $ 3,322,060 $ 2,077,353 $ 1,215,025
Adjustments to reconcile net income to net cash provided by operating activities:      
Goodwill impairment 0 0 256,649
Depreciation and amortization 363,344 333,335 348,049
Loss on extinguishment of debt 0 0 22,538
Unrealized foreign exchange (gain) loss and other 46,531 (19,441) 13,860
Asset impairment charges 5,962 842 13,341
Stock-based compensation expense 126,918 111,836 111,381
Deferred income taxes (329,501) (44,445) (93,110)
Gain on sale of business 0 (4,422) 0
Gain on fair value adjustment of marketable equity securities 0 (26,719) 0
Settlement of treasury lock agreement 82,799 0 (21,518)
Changes in assets and liabilities, net of assets acquired and liabilities assumed in business acquisitions:      
Accounts receivable (510,326) (203,155) (118,362)
Inventories (567,003) (270,100) (74,817)
Other assets (217,070) (96,218) (11,147)
Accounts payable 101,632 79,366 61,144
Deferred system revenue 213,368 (44,674) 57,687
Deferred service revenue 129,718 45,845 22,779
Other liabilities 544,270 245,623 (24,649)
Net cash provided by operating activities 3,312,702 2,185,026 1,778,850
Cash flows from investing activities:      
Proceeds from sale of assets 27,658 1,855 0
Proceeds from sale of business 0 16,833 0
Business acquisitions, net of cash acquired (479,113) 0 (90,143)
Capital expenditures (307,320) (231,628) (152,675)
Purchases of available-for-sale securities (987,660) (1,018,744) (798,493)
Proceeds from sale of available-for-sale securities 113,538 145,533 148,969
Proceeds from maturity of available-for-sale securities 760,548 581,679 626,943
Purchases of trading securities (121,254) (107,867) (110,241)
Proceeds from sale of trading securities 116,350 111,321 115,680
Proceeds from other investments 795 614 1,086
Net cash used in investing activities (876,458) (500,404) (258,874)
Cash flows from financing activities:      
Proceeds from issuance of debt, net of issuance costs 2,967,409 40,343 741,832
Proceeds from revolving credit facility, net of costs 875,000 0 450,000
Repayment of debt (620,000) (70,000) (1,171,033)
Common stock repurchases (3,967,806) (938,607) (829,084)
Forward contract for accelerated share repurchases (900,000) 0 0
Payment of dividends to stockholders (638,528) (559,353) (522,421)
Payment of dividends to subsidiary’s non-controlling interest holders (602) 0 (1,239)
Issuance of common stock 113,014 86,098 75,634
Tax withholding payments related to vested and released restricted stock units (84,371) (56,362) (46,260)
Contingent consideration payable and other, net (1,121) 0 2,936
Net cash used in financing activities (2,257,005) (1,497,881) (1,299,635)
Effect of exchange rate changes on cash and cash equivalents (28,941) 13,460 (1,926)
Net increase in cash and cash equivalents 150,298 200,201 218,415
Cash and cash equivalents at beginning of period 1,434,610 1,234,409 1,015,994
Cash and cash equivalents at end of period 1,584,908 1,434,610 1,234,409
Supplemental cash flow disclosures:      
Income taxes paid, net 464,526 326,002 204,685
Interest paid 154,673 154,196 152,651
Non-cash activities:      
Contingent consideration payable - financing activities 16,281 (7,448) 5,326
Dividends payable - financing activities 7,028 6,285 5,978
Unsettled common stock repurchase - financing activities 0 6,000 0
Accrued purchase of land, property and equipment - investing activities $ 19,595 $ 30,615 $ 15,843